Targeting antigen-presenting cells by anti–PD-1 nanoparticles augments antitumor immunity

Recent studies in cancer research have focused intensely on the antineoplastic effects of immune checkpoint inhibitors. While the development of these inhibitors has progressed successfully, strategies to further improve their efficacy and reduce their toxicity are still needed. We hypothesized that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Ordikhani, Farideh, Uehara, Mayuko, Kasinath, Vivek, Dai, Li, Eskandari, Siawosh K., Bahmani, Baharak, Yonar, Merve, Azzi, Jamil R., Haik, Yousef, Sage, Peter T., Murphy, George F., Annabi, Nasim, Schatton, Tobias, Guleria, Indira, Abdi, Reza
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237477/
https://ncbi.nlm.nih.gov/pubmed/30333312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122700
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados